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Skin grafts from tolerant mice and from mouse radia-
tion chimeras are capable of inducing in isogeneic recip-
ients a state of transplantation immunity that is indistin-
guishable from that induced by skin grafts from alloge-
neic donors. The immunizing isografts themselves are 
not rejected; they are only the vehicles of immunization. 
The immunogenicity of the isografts is related to the 
degree of leukocyte chimerism of the donors and to the 
number of leukocytes in the dermis, and it apparently is 
mediated by the transfer of small numbers of allogeneic 
"passenger leukocytes" from the chimeras to the normal 
hosts. 
Experiments with skin allografts indicate that passen-
ger leukocytes are important immunogens under certain 
limiting conditions, e.g., when allografts are excised 
after only brief contact with their hosts. However, the 
contribution of passenger leukocytes to the aggregate 
immunogenicity of skin allografts under normal condi-
tions probably is insignificant. Skin allografts from mice 
made profoundly leukopenic by pretreatment with 
whole-body irradiation or cyclophosphamide, or from 
chimeras whose leukocytes have been replaced by those 
of prospective graft recipients, do not survive any longer 
than controls. Nevertheless, the persistent immunogen-
icity of skin isografts from allogeneic hemopoietic chi-
meras and of skin allografts from intact mice after ex-
posure of both types of donor to 1,200-R whole-body 
irradiation suggests that radioresistant, hemopoietically 
derived cells, probably Langerhans cells, might be im-
portant immunogens in skin allografts. 
Because histocompatibility antigens are shared to varying 
degrees by all nucleated cells of t he body [1], it is natural to 
assume that the permanent cellular constituents of solid tissue 
and organ allografts are capable of evoking allograft immunity. 
However, in 1967, I obtained inferential evidence that transient 
cellular constituents, namely, leukocytes trapped in allografts 
when th e grafts were taken from donors, are substantial con-
tributors to allograft immunogenicity. The evidence firs t was 
obtained serendipitously in an experiment designed to deter-
mine the fate of allografts of pw·e epidermis transplanted or-
thotopically to immunologically tolerant mice. The experiment 
involved excising areas of skin presumably containing allogeneic 
epidermis and grafting them to normal, secondary hosts of the 
same strain as the tolerant, primary ones. The secondary hosts 
then were tested with full-thickness skin allografts of the same 
specificity as t he pure epidermal ones. The idea was that 
accelerated rejection of the test grafts would indicate that 
allogeneic epidermis had been transferred by the primary grafts, 
i.e., that it had survived on the primary hosts. As a control, 
areas of nongrafted skin of primary hosts were grafted to a 
parallel group of secondary hosts also challenged with skin . 
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allografts. To my sw-prise, both groups of secondary hosts 
rejected the test grafts in accelerated, "second-set" fashion. In 
fact, the proportion of immunized secondary hosts in the group 
given the "control" isografts* was t he same as in the group 
given th e isografts presumed to contain a llogeneic epidermis. 
To confirm these results, I repeated th e experiment, but this 
time I transplanted 2 full -thickness skin grafts to each tolerant 
host, an allograft on one side and an isograft on the other. 
Thirty days later, I again retransplanted the allografts and the 
isografts to parallel groups of normal, secondary hosts. When 
these were tested with skin allografts 20 days later , all the 
recipients of the retranspla nted allografts, and about 75% of the 
recipients of the retransplanted isografts, were demonstrably 
in1mune. M oreover, although the retransplanted allografts were 
rejected in normal fashion, the retransplanted isografts showed 
no sign of rejection th emselves and appeared to be only vehicles 
for transplantation antigen [2]. 
Because I had conferred allograft tolerance on t he primary 
hosts by inoculating them at bilth with live, allogeneic bone 
marrow or spleen cells, and because this procedure resulted in 
hemopoietic cell chimerism, a permanent mixture of donor and 
host strain cells in t he circulation, the most reasonable expla-
nation of my results was that the retransplan ted isografts 
transferred enough a llogeneic blood cells from the chimeras to 
the normal hosts to immunize th e latter. Allogeneic erythro-
cytes transferred by the retransplanted isografts were not the 
immunogens because histocompatibili ty antigens are poorly 
exp1·essed on matme erytlu-ocytes [3], and purified preparations 
of erythrocytes ar e incapable of evoking skin allograft immunjty 
[ 4, 5]. In contrast, histocompatibili ty ant igens are particularly 
well expressed on leukocytes [ 1, 3], a nd hosts can be easily 
immunized to skin allografts by the parenteral injection of 
relatively small numbers of buffy coat cells [ 4]. So, I proposed 
that "contained" (allogeneic) leukocytes, acquired by the re-
transplanted isografts during their sojow-n in the to leran t pri-
mary hosts, caused the isografts to immunjze t he secondary 
hosts, and I concluded that "if the leukocyte containment 
hypothesis is correct, it raises the question ·of the extent to 
which the immunizing ability of skin grafts in general is depen-
dent on contained leukocytes" [2]. 
I was unawm·e at the time that Snell (6] ha:d proposed a 
similm· idea 10 years earlier. On t he basis of reports that 
pretreatment of graft donors with cortisone or radiation reduced 
allograft immunogenicity, and other indirect evidence, Snell 
suggested that "donor lymphocytes in the graft play a particu-
larly significant role [in the induction of transplantation im-
munity]." Nor was I t he first to report that skin isografts 
retranspla nted from chimeras could induce transplan tation im-
munity. In a study on the fate of long-tolerated mouse skjn 
allografts after retr ansplantation as isografts back to the strain 
of orjgin, Haskova, Chutna, and Beige [7] had reported that 
some secondm·y hosts responded to test skin allografts in im-
mune fashion. However, because the immunizing isografts in 
their study, as well as in 2 similm· subsequent ones [8, 9], had 
sojourned in allogeneic hosts, their immunogenicity probably 
represente~ the acquisition of allogeneic stroma or vasculature 
in addition to leukocytes. In all 3 studies the retransplanted 
• lsografts are fu lly histocompatible and acceptable, from an im-
munogenetic standpoint, because they are transplanted from donors to 
hosts of the same inbred strain. In contrast, allografts (homografts) 
ru·e transplanted from donors to hosts of genetically different strains. 
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isografts exhibited transient, focal necrosis, if not outright re-
jection, whereas the isografts in my experiment all were ac-
cepted with no sign of damage. So, the advantage of my exper-
iment, in terms of the leukocyte containment hypothesis, was 
that the retransplanted isografts always had been isografts, a nd 
th e only conceivable source of alloimmunogenicity was the 
allogeneic hemopoietic component of the primary hosts. 
Impressive, independent evidence of the potentially impor-
tant contribution of donor leukocytes to allograft immunogen-
icity soon was forthcoming. Elkins had found that the inocula-
tion of parent strain lymphocytes beneath the kidney capsules 
of genetically tolerant F 1 hybrid rats gave rise to local, invasive-
destructive lesions that mimicked those of acute renal allograft 
rejection [10]. However, whole-body irradiation of the F1 hosts 
before inoculation reduced the intensity of these graft-versus-
host (GVH) reactions in proportion to the dose of radiation, 
and lesions were not obtained in hosts that were profoundly 
Leukopenic [11]. His findings suggested to Elkins that radiosen-
sitive host cells such as leukocytes, rather than renal paren-
chyma cells, were the necessary immunogens for the GVH 
reactions, a proposal consistent with the similarly suppressive 
effect of host irradiation on the generation of local cutaneous 
GVH reactions reported by Ramseier and Billingham [12]. 
(Discussions of the critical role of passenger leukocytes as 
targets in both local and systemic GVH reactions may be found 
elsewhere [13, 14].) Moreover, striking evidence that transient 
as opposed to fixed cellular constituents of the kidney were 
sufficient immunogens for local GVH reactions was provided 
by Elkins and Guttmann in 1968 [15]. They reported that 
typical invasive-destructive lesions, including tubule degenera-
tion, occurred when normal, parent strain spleen cells were 
inoculated beneath the capsules of isogeneic, parent strain 
kidneys freshly grafted into F1 hybrid rats. This device ensured 
that the renal parenchyma was histocompatible and that the 
only local source of stimulation for the inoculated donor cells 
was circulat ing host blood cells. The authors concluded that 
damage to th e kidney itself was a nonspecific, "innocent by-
stander" effect resulting from the interaction of host and donor 
leukocytes within the kidney and that "rejection of solid organ 
grafts ... might frequently be initiated by an immune interac-
tion ' between host lymphocytes and reticuloendothelial or 
lymphoid cells which are passengers in the capillaries or peri-
vascular interstitium of the graft." 
E lkins and Guttmann also suggested that insofar as "passen-
ger leukocytesi' in organ allografts may be importa nt immuno-
genic agents ... rigorous attempts to eliminate such cells might 
be of value in clinical practice" [15].1' Indeed, the possibility of 
promoting th e survival of organ allografts by pretreating donors 
or grafts themselves with agen ts like radiation, steroids, cyto-
toxic drugs, or an tisera that eliminate leukocytes became a 
subject of intense investigation, one beyond the scope of this 
review.:j: Although encouraging results have been obtained in 
animal experiments [16-19], the clinical efficacy of donor pre-
treatment is quite controversial. Cunently, the Genetics and 
Transplantation Biology Branch of the National Institute of 
Allergy and Infectious Diseases is preparing to support a mul-
ticenter clinical trial that might resolve the controversy [20). 
I will confine myself h ere to a consideration of the role of 
passenger leukocytes in the immunogenicity and susceptibility 
to rejection of skin allografts. I will begin by reviewing experi-
ments demonstrating that skin allografts from blood cell chi-
meras contain allogeneic passenger cells; then I will present 
evidence that passenger leukocytes are the earliest immuno-
genic component of skin allografts. Finally, I will describe 
experiments that show the elimination of passenger leukocytes 
does not prolong the survival of skin allografts. 
i' Elkins and Guttmann coined the term passenger leulwcytes, which 
later was adopted by others, including me, in subsequent publications 
on the subject. 
:j: I am preparing a critical review of this topic. 
Mice 
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MATERIALS AND METHODS 
The various strains of highly inbred mice used in this investigation 
were obtained from The Jackson Laboratory, Bar Harbor, Maine, or 
were bred locally. Males and females, as well as adul ts of various ages, 
were used in the various experiments. However, care was taken to 
control sex and age differences in each experimental series. 
Induction of Transplantation Tolerance and Radiation Chimerism 
To confer tolerance, we gave mice intravenous injections, within 24 
hr of birth, of the requisite number of allogeneic spleen cells, as 
described by Billingham [21]. The hosts were demonstrably tolerant as 
adults in terms of apparently permanent acceptance of donor strain 
skin allografts. To produce radiation chimeras, adul t mice were exposed 
to 850 to 900 R of whole-body irradiation from an X-ray therapy 
machine and then received intravenous injections, within 24 hr, of 
approximately 5 X 107 allogeneic spleen cells. In experiments in which 
radiation chimeras served as the skin graft donors, the possible effects 
of radiation on the skin were controlled by use of donor mice that had 
been exposed to the same lethal dose of irradiation but reconstituted 
with isogeneic spleen cells, i.e., cells of their own strain. For the 
induction of tolerance or radiation chimerism across major (H-2) his-
tocompatibility barriers, semiallogeneic spleen cells obtained from F; 
hybrid donors were used in order to avoid GVH disease. 
Shin Grafting 
Unless indicated otherwise, the skin grafts were circles of nonactive 
belly skin approximately 15 mm in diameter. The hypodermis was 
removed, and each graft was transplanted freely to a bed prepared on 
the superficial fascia on the lateral thoracic wall and held in place by 
plaster bandages, as described by Billingham [22]. The bandages were 
removed 6 days after grafting, and the grafts were inspected daily 
thereafter. Graft rejection was defined as the complete breakdown 
(gross observation) of the superficial epidermis [22]. For simpHcity, 
most of the tabular data are presented in terms of the "proportion of 
immunized hosts." This phrase refers to hosts that unambiguously 
rejected test skin allografts in accelerated, "second-set" fashion. For 
example, in the C3H-to-A, donor-to-host strain combination, first-set 
skin allografts to normal hosts are rejected in 9 to 15 days, with a 
median rejection time of 11 days, and second-set allografts are rejected 
completely within 8 days by the same hosts, with a median rejection 
time of 6 days. Accordingly, the A strain hosts in these studies were 
considered immunized by a particular procedure if they clearly rejected 
C3H test skin allografts within 8 days. Comparable criteria, based on 
the relative rejection times of extensive series of fu·st-set and second-
set skin allografts in my laboratory, were applied to the other strain 
combinations. 
RESULTS 
Passenger Leulwcytes as Immunogens in Shin I sogi·afts 
As already indicated, the presence of passenger leukocytes in 
skin isografts first was inferred fro m the accelerated rejection 
of skin allografts on hosts that had previously accepted skin 
isografts retransplanted from tolerant mice that were leukocyte 
chimeras. The pooled results of my original experiments with 
the A-to-C3H, donor-to-host strain combination [2] and addi-
tional data are shown in the top part of Table I. Of the hosts, 
52% were immunized by isografts of normal skin and 78% were 
immunized by isografts of inflamed skin. For the latter, initially 
I used recently retransplanted isografts, but I could later 
achieve the same effect by traumatizing the donor sites of 
primary skin isografts several days before taking the grafts. In 
either case, the result appeared to reflect the presence of 
increased numbers of histologically demonstrable leukocytes in 
the inflamed isografts. The accelerated rejection of the test 
grafts was indicative of true immunization, not merely nonspe-
cific potentiation of allograft rejection by previous surgical 
manipulation, because none of the 29 hosts were immunized by 
skin isografts from normal, nontolerant donors. Moreover, it 
was unlikely that the effect could be explained by the adoptive 
transfer of latent effector cells from the tolerant hosts because 
none of the 39 hosts were immunized by skin isografts from 
deliberately immunized donors. Moreover, in other experiments 
July 1980 PASSENGER LEUKOCYTES AND SKIN ALLOGRAFTS 109 
TABLE I. Immunization with shin isografts from mouse hemopoietic chimeras 
Donors of immunizing grafts 
A mice tolerant of C3H" 
Normal skin isografts 
Inflamed skin isografts< 
Normal A mice 
A mice immune to C3H" 
A/ AxC3H radiation chimeras• 
A/ A radiation controls' 
D2/C radiation chimeras" 
D2/D2 radiation controls" 
C3H/CBA radiation chimeras' 
C3H/C3H radiation controls' 
B6 females tolerant to B6 mate• 
Normal skin isografts 
Inflamed skin isograftsr 
B6 female/male radiation chimeras' 
Normal skin isografts 
Inflamed skin isogra fts• 
B6 female/female radiation controls"' 
Hosts 
A 
A 
A 
A 
A 
D2 
D2 
C3H 
C3H 
B6 females 
B6 females 
B6 females 
"Transplanted contralaterally 20 days after the immunizing grafts. 
Donors of 
test grafts" 
C3H 
C3H 
C3H 
C3H 
C3H 
c 
c 
CBA 
CBA 
B6 males 
B6 males 
B6 males 
Histocompatibility Proportion of 
differences hosts immunized 
Major 
11/ 21 (52%) 
39/50 (78%) 
Major 0/29 
Major 0/39 
Major 59/60 (98%) 
Major 0/ 18 
Mul tiple minor 26/ 26 
Multiple minor 0/ 8 
Multiple minor 8/9 
Multiple minor 0/ 10 
Single minor 
0/ 27 
9/ 19 (47%) 
Single minor 
8/ 16 (50%) 
11/ 11 
Single minor 0/24 
b A mice given injections of (A X C3H)F, spleen cells at birth that accepted C3H skin allografts as adults. 
c Isografts obtained from a site of recent skin isografting or sUl·gical abrasion. 
d A mice that recently rejected C3H skin allografts. 
• Lethally irradiated A mice reconstituted with (A X C3H)F, spleen cells. 
' Lethally irradiated A mice reconstituted with A spleen cells. 
" Lethally irradiated DBA/2 mice reconstituted with BALB/c spleen cells. 
"Lethally irradiated DBA/2 mice reconstituted with DBA/2 spleen cells. 
1 Lethally irradiated C3H mice reconstituted with CBA spleen cells. 
i Lethally irradiated C3H mice reconstituted with C3H spleen cells. 
• C57BL/6 female mice given injections of C57BL/ 6 male spleen cells at birth that accepted C57BL/ 6 male skin grafts as adults. 
1 Lethally irradiated C57BL/ 6 female mice reconstituted withh C57BL/ 6 male spleen cells. 
"'Lethally irradiated C57BL/6 female mice reconstituted with C57BL/ 6 female spleen cells. 
the immunity was shown to be specific to the donor strain 
represented in the chimeras, i.e., test skin allografts from a 
"3rd-party" donor strain were not rejected in the same accel-
erated fashion as C3H test grafts. 
The results with A strain hosts shown in Table I illustrate 
that the immunogenicity of the isografts apparently depended 
on the degree of leukocyte chimerism of the donors. In classi-
cally tolerant mice, when tolerance is conferred by neonatal 
inoculation of F 1 hybrid donor cells, the degree of chimerism is 
very small; less than 10% of the leukocytes in the chimeras are 
of the donor type [23, 24]. In contrast, in chimerism produced 
in adult mice by whole-body irradiation and reconstitution with 
F 1 hybrid hemopoietic cells, the degree of chimerism is very 
great, and most circulating blood leukocytes are of the donor 
type [25]. Accordingly, if passenger leukocytes were responsible 
for the immunogenicity of the isografts from chimeras, isografts 
from radiation chimeras should have been more inliDunogenic 
than those taken from tolerant mice. I originally confirmed this 
prediction in 1968 [26]; more extensive results are summarized 
in Table I, where it can be seen that 98% of the A hosts were 
immunized by normal, noninflamed skin isografts from A/ 
AxC3H radiation chimeras and 52% were immunized by normal 
skin isografts from tolerant donors. As a control for any possible 
nonspecific effects of inadiation, a parallel group of 18 hosts 
received skin isografts from donors irradiated and reconstituted 
with cells of their own strain; these hosts were not immunized. 
The C3H-to-A strain combination used in the initial experi-
ments exemplifies histocompatibility differences determined by 
the H-2 or major mouse histocompatibility complex, as well as 
minor differences determined by multiple non-H-2 loci. How-
ever, as seen in Table I, skin isograft immunogenicity also was 
demonstrable in 2 strain combinations involving multiple minor 
(non-H-2) differences, as well as in the C57BL/6 male-to-female 
donor-to-host combination, in which the only histocompatibil-
ity difference was determined by the male-specific H-Y antigen. 
In this weak histocompatibility system, immunogenicity only 
was demonstrable with inflamed skin isografts from tolerant 
TABLE II. Immunization with shin isograft components from mouse 
hemopoietic chimeras" 
Skin component tested 
Full-thickness skin, trypsinized but not 
separated 
Epidermis and dermis, separated and re-
united 
Epidermis alone 
Dermis alone 
Proportion of 
hosts immunized 
6/6 
6! 6 
0/ 6 
5/ 6 
"The donors of the skin components were A mice that had been 
lethally irradiated and reconstituted with (A X C3H)F 1 spleen cells. 
The hosts were normal A mice. The donors of the test grafts, trans-
planted contralaterally 20 days after the skin components, were C3H 
mice. 
donors, but 50% of the female hosts receiving normal skin 
isografts from radiation chimeras and all those receiving in-
flamed skin isografts were immunized. These results redemon-
strated the apparent dependence of the immunogenicity of skin 
isografts from chimeras on both the degree of leukocyte chi-
merism of the donors and the number of leukocytes in the 
grafts. In experiments with the A-to-C3H strain combination 
(data not shown), the immunogenicity of skin isografts also was 
a function of the time of acquisition of leukocyte chimerism and 
its duration after i.nadiation and hemopoietic cell reconstitution 
of the donors. 
In other experiments with radiation chimeras, I found that 
skin isograft immunogenicity was not limited to any particular 
region of the body, i.e., grafts of belly, chest, tail, and ear skin 
all seemed equally immunogenic (data not shown). However, 
immunogenicity appeared to emanate from the dermis. Table 
II gives the results of an experiment in which I separately tested 
the immunogenicity of the epidermal and dermal components 
of skin isografts from radiation chimeras. The components were 
obtained by trypsinization of full-thickness tail skin, as de-
scribed by Billingham [22]. The immunogenicity of the dermal 
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component could account for the immunogenicity of the entire 
isograft, a result compatible with the idea that passenger leu-
kocytes onJy might be found in the vascularized component of 
skin. 
To get an idea of the number of passenger leukocytes in 
immunizing isografts, I counted the leukocytes in several fixed 
and sta ined sections of grafts on a light microscope, and multi-
plied the number by a factor that took the total area of the 
grafts into account. I obtained mean estimates of 37,000 and 
16,000 total leukocytes (including polymorphonuclear cells, 
lymphocytes, and macrophages) per skin graft from tolerant 
mice and radiation chimeras, respectively (the fewer leukocytes 
in the skin of the latter probably was a residual effect of 
radiation because I sampled the skin about 30 days after radia-
tion and cell reconstitution). These counts were very conserva-
tive because I only recorded cells I was sure were leukocytes. 
Nevertheless, they were threshold numbers for immunizing 
mice to skin allografts by conventional routes [27], especially if 
onJy a fraction of the leukocytes in grafts from the classically 
tolerant donors were allogeneic. However, very small numbers 
of allogeneic leukocytes could have been immunogenic when 
delivered within the skin isograft because of an adjuvant-like 
effect of the inflammatory response to skin grafting per se. To 
test this idea, I compared the immunogenicity of small numbers 
of semiallogeneic lymphocytes inoculated alone, concunently 
with skin isografts, and within the skin isografts (to accomplish 
intragraft inoculation, I injected the cells into the donor skin 
and then grafted the entire inoculation site onto the host). As 
seen in T able III, even contralateral skin isografting potentiated 
immunization by the semiallogeneic lymphocytes, and the cells 
were most immunogenic when presented within an isograft. 
Passenger Leukocytes as Immunogens in Shin Allografts 
The experim (j! nts described so far all involved the use of skin 
isografts from chimeras in which transient cellular constituents 
presumably were the only possible immunogens. Another set of 
experiments was designed to test the immunogenicity of pas-
senger leukocytes in skin allografts in which both the perma-
nent and t ransient cellular constituents were possible immu-
nogens. 
T A Bl, E III. Potentiation by skin isogr·afts of imm.u.n.i:wtion. through 
small numbers of semiallogen.eic m.ou~·e lymphocytes" 
Proportion of hosts immunized 
JmnlUniza tion procedure 
Cells injected inlradermally only 
Cells injected intradermally and hosts 
given a skin isograft cont ralate rally 
Cells injected in traderma lly into the 
skin isogra ft 
Isogeneic ce lls" injected intradermally 
into the skin isograft 
B y tO ,OOo 
cells 
0/ 12 
2/12 (lH>) 
5/12 (4 2%) 
0/ 12 
B y 50 ,000 
cells 
0/ 12 
4/ 12 (33%) 
5/ 12 (42%) 
0/ 12 
" A mice were inoculated with (A x C3H)F 1 lymph node cells at lhe 
time th e hosts were given a skin isograft fTom normal A donors, and 
the hosts were t.ested with a C3H skin a llograft 20 days later. 
1
' Lymph node cells f1·om normal A donors. 
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The motivation for the 1st experiment was 2-fold. First, 
McKhann and Berrian [28] had demonstrated that skin allo-
grafts immunize within 4 days after grafting and that daily 
interruption of the grafts with their beds prevents graft vascu-
larization but not host immunization. Second, Snell [6], in 
considering how grafts immunized their hosts, favored the view 
that "donor lymphoid cells in the graft may pass rapidly to the 
regional lymph nodes and there incite an immune response." 
Together, these facts and this hypothesis suggested that the 
initial immunization of hosts by skin allografts might be me-
diated by a rapid release of passenger leukocytes into the graft 
bed. 
To test this idea, I repeated McKhann and Berrian's experi-
ment, but used radiation chimeras and controls as donors of 
immunizing grafts. I produced fully allogeneic chimeras by 
irradjating CBA strain mice and reconstituting them with C3H 
strain spleen cells (these 2 strains are H-2-compatible, and 
reciprocal radiation chimeras can be produced without GVH 
disease). Because their hemopoietic and lymphoid tissues were 
virtually replaced by donor strain cells, the CBA/C3H chin1eras 
provided grafts in which only the skin itself was allogeneic to 
C3H hosts, i.e., the passenger leukocytes were isogeneic. For 
controls, other irradiated CBA mice were reconstituted with 
spleen cells of their own strain; these mice provided grafts to 
C3H hosts in which both the skin itself and the passenger 
leukocytes were allogeneic. For an exacting test of immunogen-
icity, skin grafts from the radiation chimeras and controls, as 
well as from intact CBA and C3H donors, were transplanted to 
a large group of normal C3H hosts and completely excised from 
the subgroups 1 to 4 days after grafting. Twelve days after 
placement of the immunizing grafts, all the hosts were contra-
laterally tested with a normal CBA skin allograft; the intensity 
of rejection of the test grafts revealed the degree of immunity 
evoked by brief contact with the immunizing grafts. The allo-
grafts presumably deficient in allogeneic passenger leukocytes 
were deficient in the capacity to immunize (Table IV). For 
example, the allografts from the CBA/C3H chimeras immu-
nized only 33% of the hosts after 4 days of contact; 82% were 
immunized by the "complete" allografts from the CBA! CBA 
controls. (These results have been reported in part elsewhere 
[29].) 
In a 2nd attempt to evaluate the contribution of passenger 
leukocytes to the immunogenicity of skin allografts, I took 
advantage of the leukocidal effect of whole-body irradiation 
[30). Skin allografts were transplanted from normal A to C3H 
mice, and immediately thereafter the donors were treated with 
1,200 R of X-irradiation. Four days later, when total leukocyte 
counts had dropped to a minimum (30], a 2nd allograft was 
transplanted from each A donor to a 2nd group of C3H mice. 
The recipients of both sets of allografts were then divided into 
2 subgroups: a subgroup in which the allografts were excised 2 
days after grafting and a subgroup in which the allografts were 
left in place, to be rejected naturally. However, 20 days after 
placement of the primary grafts, the hosts in all the subgroups 
were contralaterally tested with a normal A skin a.llog1·aft. As 
seen in the top part of Table V, donor irradiation markedly 
reduced the immunogenicity of the allografts with the 2-day 
TABLE IV . Tmmun.ization. by brief contact with shin. isografts or allografts from normal mice or {rom radiation chimeras and controls 
Days of 
co \\tac tfl 
1 
2 
3 
4 
From in tact CBA mice 
2/12 (17%) 
4/ 12 (33%) 
8/ 12 (67%) 
11/ 12 (92%) 
Proportion of C:lH hosts immunized by grafts 
From CBA/CBA controls'' 
l / 12 (8%) 
l / 12 (8%) 
8/12 (67%) 
14/ 17 (82%) 
From CBA/ C3H chimeras' 
0/ 12 
0/12 
1/11 (9%) 
4/ 12 (33%) 
From in tact C3H mice 
0/ 12 
0/ 12 
0/ 12 
0/12 
" The immunizing grafts were excised 1 to 4 days after grafting as indicated, but all the hosts were challenged with a CBA test skin allograft at 
the same time, 12 days a fter the placement of th e immunizing grafts. ' ' 
"CBA mice that had been lethally irradiated and reconstituted with CBA spleen cells. 
c CBA mice that had been lethally irradiated and reconstituted with C3H spleen cells. 
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TABLE V. Effect of donor irradiation on the imm.unogen.icity of skin allografts from normal mice and of shin isogra.fts from radiation 
chimeras 
Donors of Hosls Donors of Contact 
Proportion of hosts immunized 
in1n1unizing grafts test grafls time By !,'Tafls before irradiation By grafts after irradiation" 
Intact A mice C3H A 2 days 13/ 16 (81%) 1/12 (8%) 
Intact A mice C3H A 9-14 days" 18/ 18 10/ 12 (83%) 
C3H/ AxC3H chimeras·· C3H A 2 days 11112 (92%) 3112 (25%) 
C3H/ AxC3H chimeras" C3H A 
AI AxC3H chimeras" 
20 days 24 / 24 22124 (92%) 
A C3H 2 days 15/ 16 (94%) 6118 (33%) 
A I AxC3H chimeras" A C3H 20 days 13115 (87%) 14115 (93%) 
C3HICBA chimeras•· C3H CBA 2 days 12112 1111 (9%) 
C3HICBA chimeras" C3H CBA 20 days 12112 10111 (91 %) 
" The grafts were taken just before a nd 4 days after whole-body exposure of the donors to 1,200 R of X- irradiation. 
"The immunizing grafts either were excised 2 days afte r grafting, or were left in place. In the latter case, t he A-to-C3H allografts were rejected 
within the days indicated, but aU the isografts were in tact at the time of test grafting, 20 days after placement of t he immu nizing grafts. 
• C3H mice that had been lethally iradiated and reconstituted with (A x C3H)F 1 spleen ce lls. 
"A mice that had been lethally irradiated and reconstituted with (A X C3H)F 1 spleen cells. 
• C3H mice that had been letha lly irradiated and reconstituted with CBA spleen cells. 
TABLE VI. Effect of donor pretreatment with leuhocidal agents on the survival of mouse shin. allografts 
StTain Agent Dose Days before No. 
Graft survival times (days) 
combination grafting grafts Median± CL" Range 
A-to-C3H1' None (control) 0 76 10.6 ± 0.3 9-14 
Whole-body 300 R 1 10 10.2 ± 0.6 9-12 
irrad iation 850R 3 12 11.0 ± 0.8 9-13 
850 R 6 7 10.9 ± 0.6 10-13 
1,200 R 4 12 7.9 ± 1.0 8-12 
Cyclophosphamide 100 mgl kg 4 8 11.9 ± 1.7 10-12 
CBA-to-C3H' None (control) 0 50 ll.8 ± 0.4 10-1 7 
Whole-body 
irradiation 1,200 R 4 12 11.1 ± 0.6 10-14 
" Median survival time ± 95% confidence limi ts (CL) computed by the nomograph method of Li tchfie ld [31]. 
"Major plus multiple minor histocompatibility differences. 
• Multiple minor histocompatibility differences only. 
contact time (81% versus 8%), but had little effect on the 
immunogenicity of the allografts left in place (the difference 
between 18/ 18 and 10/ 12 is not significant statistically). 
In view of these results, I decided to re tw-n to kin iso)5J·afts 
from chimeras and to test the effect of donor irradiation on t he 
immunogenicity of grafts in which passenger· leukocytes· pre-
sumably were the only possible immunogens. I used the same 
strategy as above, namely, I tested the i.mmunogenicity of skin 
grafts before and after donor irradiation following a 2-day (or 
in this case, a 20-day) contact t ime. As seen in the rest of Table 
V, tests with 3 strain combinations essent ially had the same 
results: donor irradiation significantly reduced the ability of 
isografts with t he 2-day contact t ime to immunize, but had 
surprisingly li ttle effect on t he immunogenicity of the isografts 
left in place unt il test grafting. These resul ts suggest a radi-
oresistant hemopoietic cell derivative is a sow·ce of immuno-
genicity in skin allografts under "normal" conditions, i.e., when 
skin allografts are not deliberately excised a few days after 
grafting. 
Passenger Leu.lwcyte E limination and Slzin Allograft 
S urvival 
Up to this point, the experiments all concerned the possible 
contribu tion of passenger leukocytes to the immunogenicity of 
skin allografts--the abili ty of skin allografts to evoke t he im-
munologic reactions that result in their rejection. The next 
series of experiments was designed to determine if removal of 
passenger leukocytes would affect the fate of skin allografts. 
Specifically, would the elimination of passenger leukocytes 
delay skin allograft rejection? 
I first attempted to answer this question by comparing the 
sw-vival times of skin allografts from donors made severely 
leukopenic by treatment with whole-body irradiation or cyclo-
phosphamide (CY) with those of grafts from controls. The 
regimen of pretreatment with CY produced profound leuko-
penia, as had the regimen of pretreatment with the higher doses 
of rad iation; the mean leukocyte count in the 8 individual CY-
treated donors was 165 ± 83 (SD) cells/ mma of blood. As seen 
in Table VI, such donor pretreatment did not prolong skin 
allograft sw-vival in the 2 strain combinations tested. In fact, 
the only statistically significant result is the slightly decreased 
median survival tin1e of the allografts from the A strain donors 
exposed to 1,200 R. I deliberately tested allografts taken 24 Iu 
after exposure of the donors to 300 R in 1 experiment because 
Hardin and Werder had reported in 1954 that this procedure 
significantly prolonged the survival of skin allografts within a 
"heterozygous" mouse strain (32]; obviou ly, I did not confu·m 
their findings with t he inbred A-to-C3H strain combination . 
Perhaps any beneficial effect on graft sw-vival of eliminating 
passenger leukocytes in the above experiments might have been 
negated by ·nonspecific injmious effects of the donor pretreat-
ment; the shorter med ian smvival time of the allografts from 
the donors irradiated with 1,200 R (Table VI) might have 
exemplified such injmy. ·Others have reported that skin allo-
grafts from heavily irradiated donors have shorter survival 
times or exhibi t signs of nonspecific damage (33-36]. Accord-
ingly, t he effect of passenger leukocyte elimination on skin 
allograft sw-vival was evaluated more decisively in experiments 
with radiation chimeras and controls as donors. In each of 4 
str ain combinations, 1 with major histocompatibility differ-
ences, 2 with mul tiple minor differences, and 1 with a single 
minor difference, the survival times of skin allografts from 
donors exposed to a lethal dose of whole-body irradiation and 
reconstituted with hemopoietic cells of t he prospective host 
strain, and of allografts from donors similarly irradiated but 
reconstituted with cells of their own strain, were compared to 
t hose of a large series of fu·st-set skin allografts from normal 
donors. This method ensw·ed ·that all nonspecific effects of 
112 STEIN MULLER Vol. 75, No. 1 
TABLE VII. Survival of skin allografts from mouse radiation chimeras and controls 
Strain 
combination 
A-to-C3H 
Histocompatibility 
differences 
Major 
Graft 
donor(' 
Intact A 
No. Graft survival times (days) 
grafts Median± CL" Range 
76 10.6 ± 0.3 9-14 
AI A controls 10 11.1 ± 1.2 9-14 
A/C3H chimeras< 11 11.7 ± 0.6 9-14 
CBA-to-C3H Multiple minor Intact CBA 50 11.8 ± 0.4 10-17 
CBA/CBA controls 17 10.4 ± 0.4 10-13 
CBA/C3H chimeras 17 10.7 ± 0.6 9-14 
DBA/2-to-BALB/c Multiple minor Intact D2 64 13.3 ± 0.3 11-17 
(D2) (C) D2/D2 controls 12 11.8 ± 1.7 9-16 
D2/C chimeras 12 11.8 ± 0.7 10-15 
C57BL/6 (B6) 
male-to-female 
Single minor Intact B6o 48 27.6 ± 3.0 13-84 
B6o/B6o controls 12 22.3 ± 2.0 15-30 
B6o/B6'i' chimeras 12 20.9 ± 2.8 12-37 
"The symbol to the left of the slash line gives the mouse strain that had been lethally irradiated, and that to the right gives the mouse strain 
that supplied the reconstituting hemopoietic cell inocula, e.g., A/ A skin graft donors were irradiated A mice reconstituted with A spleen cells, and 
A/C3H donors were irradiated A mice reconstituted with C3H spleen cells. 
"Median survival time ± 95% confidence limits (CL) computed by the nomograph method of Litchfield [31]. 
c Graft-versus-host disease was prevented in these H-2 incompatible chimeras by early treatment of the hosts with methotrexate, as described 
by Lochte et al [37]. 
irradiation were controlled and that the only variable was the 
presence or absence of allogeneic passenger leukocytes in the 
allografts. As seen in Table VII, the fate of the allografts was 
not a function of this variable. In all cases the allografts were 
taken from irradiated-reconstituted donors at a time when 
virtually all their peripheral blood leukocytes had the specificity 
of the hemopoietic cell inoculum (data· not shown) . 
DISCUSSION 
The results in Table I-III indicate that enough allogeneic 
cells are transferred within the vasculature and stroma of skin 
isografts from chimeras to induce a state of transplantation 
immunity that, in terms of intensity and specificity, is indistin-
guishable from the state induced by skin allografts from normal 
donors. As discussed elsewhere [2, 38], in theory any cells 
derived from allogeneic myeloid and lymphoid tissues of chi-
meras could be responsible for the immunogenicity of isografts. 
However, leukocytes are the logical choice because of their high 
content of histocompatibility antigen [1, 3] and their proven 
ability to induce skin allograft immunity [ 4]. These qualities, 
plus the "ameboid motility of the leukocyte and the abundant 
lymphatic capillaries in the skin," led Snell to propose that 
allografts first made their presence known by rapidly releasing 
passenger leukocytes to the regional lymph nodes [6]. The later 
autoradiographic demonstration by Elves that lymphocytes 
inoculated into rat skin rapidly migrated to the regional lymph 
nodes [39] gave anatomical support to Snell's proposal. 
Other support for the passenger leukocyte concept came from 
Barker and Billingham, who demonstrated that well-trimmed, 
relatively small, full-thickness parent strain skin grafts incited 
GVH reactions in draining lymph nodes of F 1 hybrid mice and 
rats, presumably through mediation of the donor lymphocytes 
that migrated from the grafts to the nodes via the afferent 
lymphatics [ 40]. Moreover, striking evidence of the transfer of 
hemopoietic stem cells by skin grafts came from the work of 
Wachtel and Silvers (reviewed elsewhere in this issue [41]), 
who showed that allografts of neonatal mouse skin could confer 
leukocyte chimerism on adult hosts in certain circumstances 
[42]. 
However, that passenger leukocytes.exist in skin grafts is one 
matter; that they are responsible for graft immunogenicity is 
another. For example, Wachtel and Silvers' evidence that skin 
grafts contain hemopoietic stem cells is indisputable, but it 
comes from experiments on the role of passenger leukocytes in 
the tolerogenicity of skin allografts in certain minor histocom-
patibility systems, a well-established but anomolous phenome-
non only achievable with skin allografts from fetal or neonatal 
donors [ 42, 43]. Similarly Barker and Billingham [ 40] showed 
that there are enough lymphocytes in skin allografts to effect 
regional GVH reactions, but this does not prove that these cells 
are significant graft immunogens. 
As for my own work, the results in Tables I-III were contrived 
in the sense that they were obtained in experiments with skin 
isografts in which passenger cells were the only possible im-
munogens: Consequently, my co-workers and I designed exper-
iments to directly test the role of passenger leukocytes in the 
immunogenicity of skin allografts. The device of excising grafts 
1 to 4 days after grafting allowed us [29] to confirm McKhann 
and Berrian's earlier observation [28] that host immunization 
occurred within a few days after grafting (Table IV). Moreover, 
the fact the allografts deficient in passenger leukocytes were 
much slower to immunize strongly suggested that Snell [6] was 
right and that the rapid release of passenger cells initiated the 
process. 
The rationale for the next experiment was that if the release 
of passenger leukocytes was an important pa1·t of the immuni-
zation process, allografts from donors made profoundly leuko-
penic by whole-body irradiation would have reduced immuno-
genicity. There was reduced immunogenicity when the skin 
allografts were excised after 2 days, but not when the allografts 
were left in place for the hosts themselves to reject (Table V, 
top). The latter observation is particularly significant because 
it indicates that passenger leukocytes only may be important 
irnmunogens during the very early phase of host immunization. 
To test this idea, I returned to the chimera model and tested 
the effect of donor irradiation on the immunogenicity of skin 
isografts in which passenger leukocytes were the only immu-
nogens. The results were the same (Table V, bottom); only the 
immunogenicity of the 2-day excised grafts was reduced signifi-
cantly by donor irradiation. Insofar as the only somce of im-
munogenicity for the isografts was the allogeneic hemopoietic 
system of the chimera donors, a radioresistant hemopoietic 
derivative had to be responsible for the immunogenicity of the 
isografts left in place. (I will speculate about the natme of this 
radioresistant component later.) 
The fmal, and most clinically relevant, goal of the investiga-
tion was to determine whether the elimination of passenger 
leukocytes would promote the survival of skin allografts. Un-
fortunately, the smvival times of skin allografts from donors 
made profoundly leukopenic by treatment with X-rays or CY 
were not prolonged (Table VI) . This result, not entirely unex-
pected because of the inability of donor irradiation to affect the 
irnmunogenicity of undisturbed skin allografts (Table V), con-
flicted with results reported by Hardin and Werder in 1954 and 
1955 [32, 44]. They claimed that the rejection of skin grafts 
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TABLE VIII. Immunogenicity of pure epidermal allografts in mice 
Strain 
combination 
A-to-C3H 
C3H-to-A 
BALB/c-to-C3H 
(BALB/c x C3H)F,-
to-C3H 
C57BL/6-to-C3H 
C57BL/6 male-to-
female 
Histocompatibility 
differences 
Major 
Major 
Major 
Major 
Major 
Minor 
" Transplanted 20 to 30 days before the test grafts. 
transplanted within the "heterozygous" CFW strain was sig-
nificantly delayed when the donors received 300-R whole-body 
irradiation 24 hr before grafting; that 13 of 40 such grafts 
survived at least 1 yr; and that all grafts from nonirradiated 
controls were rejected within 10 days. These incredible results 
have never been confirmed with inbred animals, and they 
probably reflect the chance histocompatibility of some of the 
noninbred mice used by these investigators. Kyger and his 
collaborators first reported that 4 of 18 rat skin allografts from 
donors exposed to BOO R 2 wk before grafting "were in perfect 
condition at 100 days" [ 45). However, subsequently they wrote, 
"We have not succeeded in repeating this phenomenal prolon-
gation of survival time, and these animals have been dropped 
from the group in this report" [ 46]; the remaining grafts in the 
treated group and those in the control group had mean survival 
times of 11.6 days and 8 days, respectively. In 4 other studies, 
murine skin allografts from irradiated donors either were not 
prolonged significantly or were rejected earlier than controls 
[33- 36). Collectively, the results of our attempts to delay rejec-
t ion of skin allografts by donor or graft pretreatment with other 
leukocidal agents, steroids, and antileukocyte sera are similarly 
inconclusive.§ 
The failul'e to promote skin allograft SUJ'vival by donor irra-
diation or treatment with CY (Table VI) might have resulted 
from an unfavorable benefit: injury ratio of the donor pretreat-
ment. However, this cannot explain the failure to promote graft 
survival in the experiments with chimera donors, in which any 
possible injurious effects of donor irradiation were controlled 
and the only varia ble was the presence or absence of passenger 
leukocytes (Table VII) . Skin allografts from donors whose 
peripheral blood leukocytes were virtually all of host specificity 
survived no longer than controls in 4 strain combinations rep-
resenting major, multiple minor, and single minor histocompat-
ibility differences. There are 2 other reports in the literature on 
the fate of skin allografts from chimeras. Streilein and Bil-
lingham observed about a 4-day prolongation in the median 
sUJ'vival t ime of skin allografts from hamster chimeras, and the 
prolongation was a function of the time the grafts had been 
taken after hemopoietic cell reconstitution of the. donors [ 4 7]; 
the median survival times were 9.5 and 8.6 days, respectively, 
for the grafts taken 2 and 4 wk after cell reconstitution, but 13.2 
and 12.4 days for the grafts taken after 6 and 8 wk. The 
investigators interpreted this as a cmde indication "of the 
extent to which passenger leukocytes contribute to the antigenic 
stimulus of a solid tissue homograft such as skin." In my tests 
with skin allografts from chimeras (Ta ble VII) the grafts were 
taken 20 to 30 days after donor irradiation and cell reconstitu -
tion, and it is conceivable that if I had waited longer, I would 
have found the kind of modest prolongation reported by Strei-
lein and Billingham (I took the grafts at this time because I 
knew that as isografts they were already fully immunogenic). 
However, Nouza et al [36], using an inbred mouse strain com-
§ Steinmuller D, Warren RP, Shelby J, unpublished data. 
Immunizing Proportion of 
allografts" hosts immunized 
Full-thickness skin 28/ 28 
Pure epidermis 22/ 22 
Full-thickness skin 67/ 67 
Pure epidermis 20/21 (95%) 
Full-thickness skin 16/ 16 
P ure epidermis 7/ 15 (47%) 
Full-thickness skin 12/ 12 
Pme epidermis 14/ 26 (54%) 
Full-thickness skin 11/ 11 
Pure epidermis 10/ 12 (83%) 
Full-thickness skin 13/ 15 (87%) 
Pure epidermis 22/ 24 (92%) 
bination with minor histocompatibility differences, found the 
survival of skin allografts from chimeras was not prolonged at 
all in either normal-serum-pretreated or antilymphocyte-se-
rum-pretreated hosts, and the grafts were taken 2 mo after 
irradiation and cell reconstitution of the donors. In fact, the 
grafts from the chimeras did not survive as well as those from 
controls in the antilymphocyte-serum-pretreated hosts. 
Collectively, the results of my investigations create an appar-
ent dilemma: passenger leukocytes seem to be impor tant im-
munogens in skin allografts soon after grafting (Table IV and 
Table V) and yet their elimination or replacement does not 
delay skin allograft rejection (Table VI and Table VII). If 
passenger leukocytes really contribute to allograft immunogen-
icity, why does their removal not promote allograft survival? 
The answer, I am afraid, is that passenger leukocytes, at least 
as originally conceived [2, 15], really do not contribu te signifi-
cantly to the inmmnogenicity and fate of skin allografts [34- 36, 
46, 47M/ a conclusion reached earlier by Billingham [13]. The 
evidence that they do was obtained under contrived or limiting 
condi tions, i.e. , the use of skin isografts from chimeras in which 
hemopoietically derived passenger cells were the only possible 
source of alloantigen (Table I) and the device of excising grafts 
from their beds during the fu·st few days after grafting (Table 
IV) , that exaggerated their importance. For example, deposition 
of passenger leukocytes into t he graft bed may be the most 
significant way a skin allograft immunizes its host when the 
graft is excised 2 days after transplantation, but the relative 
contribution of passenger cells is insignificant compared to that 
of fixed constituent of the graft when the graft is left in place 
for natmal rejection (Table V). This situation is analogous to 
the role of a lawn sprinkler in a rain storm; its relative contri-
bution to the soaking of the lawn is significant when the storm 
is beginning, but is insignifican t once the storm is under way. 
If the contribution of the transient cells is insignificant, the 
permanent cells of the skin must be the main source of allograft 
immunogenicity. In this regard, there is no doubt that the 
epidermis itself is immunogenic, both in vivo (48-51] and in 
vitro [52, 53). For example, Table VIII shows the results of 
in1munizing mice with either full-thickness skin or pme epider-
mal . allografts. In spite of the fact that they lacked dermis 
(which contains the bulk of th e follicular epithelium and the 
passenger leukocytes), allografts of pure, superficial epidermis 
were not significantly less immunogenic than full-thickness 
allografts in 4 of the 6 strain combinations tested. These results 
confu·med those of Billingham and Sparrow [ 48], who reported 
in 1954 that pw·e epidermal allografts in rabbits evoked and 
succwnbed to transplantation immunity, even though they 
survived slightly longer than split-thickness skin allografts of a 
similar ru:ea. 
Attributing the main sow·ce of immunogenicity to the epi-
11 Although the evidence that passenger leukocytes contribu te to the 
inmlUnogenicity of organ allografts is controversial, they are, no doubt, 
important immunogens and tru·gets in GVH reactions [13-15]. 
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dermis does not exclude an important role for hemopoietically 
derived cells. Previously I referred to the surprising radioresist-
ance of the immunogenicity of skin isografts from chimeras; in 
3 strain combinations, isografts from chimeras made profoundly 
leukopenic by whole-body irradiation were as capable of evok-
ing allograft immunity as those from nonirradiated controls, as 
long as they were not excised 2 days after grafting (Table V). 
Because macrophages arise fro m the bone marrow (54) and 
because these cells are radioresistant [55-57],** the persistent 
immunogenicity of the grafts from the irradiated donors might 
be accoun ted for by macrophages or macrophage-like cells in 
the skin. In view of the analogous functions of macrophages and 
Langerhans cells in the ini tiation of the immune response (a 
subject reviewed in detail by several other contributors to t his 
issue) and the postulated role of epidermal Langerhans cells as 
"sensitizing cells" in skin allograft rejection [58), Langerhans 
cells are possible sources of persistent immunogenicity in iso-
grafts from irradiated donors, especially because of the new 
evidence that they originate in bone marrow. Frelinger et al 
and Katz, Tamaki, and Sachs rece ntly reported that donor 
strain Ia antigens were expressed by cells in the epidermis of 
mouse radiation chimeras [59-62]. Because the hemopoietic 
system of the chimeras virtually was replaced by donor bone 
marrow cells, and because it has been well establish ed that 
Langerhans cells in mouse epidermis express Ia antigens (63, 
64), the independent reports of Frelinger et al [59] and Katz, 
Tamaki, and Sachs [60] are strong evidence of the bone marrow 
origin of epidermal Langerhans cells.tt 
If Langerhans cells are radioresistant, bone-marrow-derived, 
potential immunogens in the epidermis, why did the immuno-
genicity appear to emanate entire iy from the dermis in my 
experiment with skin isograft comr onents from chimeras (Table 
II)? The answer may lie in the fact t hat I conducted the 
experiment only 20 days after irradiation and cell reconstitution 
of the donors. rt ·is obvious from the data in Table II that the 
full-thickness grafts were fully immunogenic at t his time and 
presumably reflected the presence of sufficient allogeneic pas-
senger leukocytes in the dermis to immunize the hosts. How-
ever, because of their very slow tumover [65], the indigenous 
Langerhans cells of the host epidermis may not yet have been 
replaced by eno1,1gh allogeneic donor cells to endow the pure 
epidermal grafts with significant immunogenicity. The data of 
Frelinger et al [59) indicate host Langerhans cells are com-
pletely replaced by donor strain cells in rad iation chimeras after 
3 mo. Accordingly, I intend to repeat the experiment reported 
in Table II, but will allow at least 3 mo to pass after irradiation 
and cell reconstitution before testing the immunogenicity of the 
skin isograft components. 
When I first reported the abili ty of skin isografts from toler-
ant, chimeric donors to induce allograft immunity, I suggested 
that the immunogenicity "might be based on the presence of 
stem cells in the inocula that confer tolerance; these cells could 
give rise to components of the skin itself, in addition to blood 
cells" [2]. At that time, I was thinking of the possible blood cell 
origin of vascular endothelium (66) and of "theliolymphocytes" 
[67-69]. However, the new information on the origin and func-
tion of epidermal Langerhans cells (reviewed here and else-
where in this issue) gives new meaning to my suggestion. The 
really important immunogens in skin allografts may not be 
passenger leukocytes, but rather Langerhans cells or "resident 
• • There is controversy about the radioresistance of thei1· postphag-
ocytic functions [57), but as physical entities macrophages are quite 
radioresistant. Bloom observed no histopathological signs of damage to 
macrophages in the bone marrow of mice, rats, or rabbits exposed to 
800 R [55], and Meyer and Dannenberg washed equal numbers of 
macrophages from the lungs of control rabbits and rabbits given -ina-
diaLion doses of 400 rads [56). 
tt lt is s till controversial whether Langerhans ce lls are the only cells 
in mouse epidermis that express Ia antigens [59, 63, 64). However, if 
the keratinocytes in the chimeras used in these 2 studies also synthe-
sized Ia antigens, the ant igen would be of host, not donor, specificity. 
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leukocytes," as first proposed by Sting! and his collaborators 
[58). 
The original experiments described in this article were conducted 
with the technical assistance of Linda Labinsky, Cecil Congleton, Earl 
Hrut, and Jane Shelby. 
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